methotrexate and clay
methotrexate has been researched along with clay in 6 studies
Research
Studies (6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Mills, DK; Sun, L | 1 |
| Alothman, ZA; Choi, G; Choy, JH; Piao, H; Vinu, A; Yun, CO | 1 |
| Basu, R; Das, S; Kar, S; Kundu, B; Nandy, P; Reis, RL; Sarkar, R | 1 |
| Li, J; Liu, D; Pan, W; Qiao, S; Tan, G; Yu, Y | 1 |
| Cavallaro, G; García-Villén, F; Lazzara, G; Massaro, M; Muratore, N; Notarbartolo, M; Poma, P; Riela, S; Sánchez-Espejo, R; Viseras Iborra, C | 1 |
| de Melo Barbosa, R; Emili, C; Liotta, LF; Massaro, M; Notarbartolo, M; Poma, P; Raymo, FM; Riela, S; Sànchez-Espejo, R; Vago, R; Viseras-Iborra, C | 1 |
Other Studies
6 other study(ies) available for methotrexate and clay
| Article | Year |
|---|---|
Halloysite nanotube-based drug delivery system for treating osteosarcoma.
Topics: Aluminum Silicates; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Clay; Drug Carriers; Humans; Methotrexate; Nanotubes; Osteosarcoma | 2014 |
Anionic clay as the drug delivery vehicle: tumor targeting function of layered double hydroxide-methotrexate nanohybrid in C33A orthotopic cervical cancer model.
Topics: Aluminum Silicates; Animals; Anions; Antimetabolites, Antineoplastic; Cattle; Cell Proliferation; Cell Survival; Clay; Drug Delivery Systems; Female; Humans; Hydroxides; Methotrexate; Mice; Nanoparticles; Tissue Distribution; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2016 |
Curcumin ameliorates the targeted delivery of methotrexate intercalated montmorillonite clay to cancer cells.
Topics: Antineoplastic Agents; Bentonite; Cell Survival; Cetrimonium; Clay; Curcumin; Drug Carriers; Drug Liberation; Folate Receptor 2; Folic Acid Antagonists; HeLa Cells; Humans; MCF-7 Cells; Methotrexate | 2019 |
A Non-innocent Magnesium Organoclay-Based Drug Vehicle for Improving the Cancer Therapy Effect of Methotrexate.
Topics: Animals; Antimetabolites, Antineoplastic; Biological Availability; Clay; Female; Gels; Humans; Magnesium Compounds; MCF-7 Cells; Methotrexate; Mice; Nanostructures; Neoplasms, Experimental; Particle Size; Pharmaceutical Vehicles | 2019 |
Prodrug based on halloysite delivery systems to improve the antitumor ability of methotrexate in leukemia cell lines.
Topics: Antineoplastic Agents; Biotin; Cell Line; Clay; Humans; Leukemia; Methotrexate; Nanotubes; Prodrugs; Spectroscopy, Fourier Transform Infrared | 2022 |
Exploring the cellular uptake of hectorite clay mineral and its drug carrier capabilities.
Topics: Clay; Drug Carriers; Methotrexate; Silicates | 2022 |